Engineered AAVs for efficient noninvasive gene delivery to the central nervous system
Key findings
Developed PHP.eB through directed evolution showing 40-fold enhanced CNS transduction versus AAV9. Enabled widespread brain expression after IV injection with reduced vector dose requirements.